← Leaderboards
Cheri Marie Ackerman
Broad Institute, Inc.
$91,470
Attributed
$91,470
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $61.6K · FY2019–20$100K$75K$50K$25K$0
'19
'20
Funding mix
By agency
NIH$91,470 · 1
By mechanism
F32$91,470 · 1
Top collaborators
No co-investigators on record.
Most similar at Broad Institute, Inc.
Same institution · by research overlap
- Catherine Ju-Ying Wu$43,266,044
- David R Liu$34,362,066
- Esther Rheinbay$1,235,271
Others in their field
Other Emerging Leaders on “Acute Lymphoblastic Leukemia Cell”
- James Even Voss · Scripps Research Institute, The$3,748,629
- Weiqiang Chen · New York University$3,255,344
- Amanda M Schalk · Enzyme By Design, Inc.$3,243,476
- Terry J. Fry · University Of Colorado Denver$3,169,598
- Hong Wen · Van Andel Research Institute$3,004,575
- Kara Lynn Davis · Stanford University$2,910,165
Research focus
Acute Lymphoblastic Leukemia CellAdverse EffectsAutomobile DrivingAcute Lymphocytic LeukemiaBisulfite SequencingCancer RelapseCdkn2a GeneCell CycleCell LineCell ProliferationCellsCell TypeChemical GeneticsChemotherapyChip-SeqCollectionCombinatorialCombined Modality TherapyCompanionsCrispr/Cas TechnologyCyclin-Dependent Kinase Inhibitor 2aDatabasesData SetDerepression
Grant awards (2)
Discovery of compounds and genes that regulate cancer's epigenome, using combinatorial screening in a nanodrop-microwell platform$29,860
F32 · FY2020 · CA · contact PI
Discovery of compounds and genes that regulate cancer's epigenome, using combinatorial screening in a nanodrop-microwell platform$61,610
F32 · FY2019 · CA · contact PI